143 related articles for article (PubMed ID: 11800086)
1. Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report.
Kitabata Y; Sakurane M; Orita H; Kamimura M; Siizaki K; Narukawa N; Kaketaka A; Abe T; Kobata H; Akizawa T
Ther Apher; 2001 Dec; 5(6):484-90. PubMed ID: 11800086
[TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid.
Yamada H; Yaguchi H; Takamori K; Ogawa H
Ther Apher; 1997 May; 1(2):178-82. PubMed ID: 10225767
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment by double-filtration plasmapheresis of a patient with bullous pemphigoid: effects in vivo on transcripts of several genes for chemokines and cytokines in peripheral blood mononuclear cells.
Hatano Y; Katagiri K; Arakawa S; Umeki T; Takayasu S; Fujiwara S
Br J Dermatol; 2003 Mar; 148(3):573-9. PubMed ID: 12653753
[TBL] [Abstract][Full Text] [Related]
4. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid.
Ahmadpoor P; Beck M; Michel M; Pambrun E; Stoebner P; Moranne O
J Clin Apher; 2024 Jun; 39(3):e22133. PubMed ID: 38881050
[TBL] [Abstract][Full Text] [Related]
5. Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
Nasu K; Hanafusa N; Nangaku M
J Clin Apher; 2017 Dec; 32(6):589-591. PubMed ID: 27709645
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis as a steroid saving procedure in bullous pemphigoid.
Egan CA; Meadows KP; Zone JJ
Int J Dermatol; 2000 Mar; 39(3):230-5. PubMed ID: 10759969
[TBL] [Abstract][Full Text] [Related]
7. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
[TBL] [Abstract][Full Text] [Related]
8. Failure of double filtration plasmapheresis to treat severe pemphigus vulgaris: A case report.
Liu Y; Wang F
J Clin Apher; 2023 Aug; 38(4):491-494. PubMed ID: 36579441
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia in autoimmune bullous disease patients undergoing double-filtration plasmapheresis.
Ohata C; Koga H; Saruta H; Ishii N; Nakama T
J Dermatolog Treat; 2019 Jun; 30(4):402-404. PubMed ID: 30221572
[No Abstract] [Full Text] [Related]
10. Resistant oral mucosal lesions in pemphigus vulgaris responsive to double filtration plasmapheresis: First case report from Turkey.
Savk E; Uslu M; Yavaşoğlu I; Kadıköylü G; Sendur N; Karaman G
Transfus Apher Sci; 2013 Apr; 48(2):273-5. PubMed ID: 23415411
[TBL] [Abstract][Full Text] [Related]
11. Double-filtration plasmapheresis combined with immunosuppressive treatment for severe pemphigus: 10 years' experience of a single center in China.
Liu Y; Zhang B; Ma J; Wang H; Fan X; Zheng K; Chen L; Li X; Qin Y; Li L; Li X
J Clin Apher; 2021 Feb; 36(1):20-27. PubMed ID: 32812668
[TBL] [Abstract][Full Text] [Related]
12. Plasmapheresis therapy of pemphigus and bullous pemphigoid.
Roujeau JC
Semin Dermatol; 1988 Sep; 7(3):195-200. PubMed ID: 3153444
[TBL] [Abstract][Full Text] [Related]
13. Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.
Herrero-González JE; Sitaru C; Klinker E; Bröcker EB; Zillikens D
Clin Exp Dermatol; 2005 Sep; 30(5):519-22. PubMed ID: 16045683
[TBL] [Abstract][Full Text] [Related]
14. Bullous Pemphigoid Successfully Treated With a Combination Therapy of Plasmapheresis Followed by Intravenous High Dose Immunoglobulin.
Hattori Y; Takahashi T; Seishima M
Ther Apher Dial; 2017 Aug; 21(4):421-423. PubMed ID: 28378368
[No Abstract] [Full Text] [Related]
15. A case of bullous pemphigoid successfully treated by plasmapheresis: assessment of the change in titers of circulating antibodies by immunoblotting and enzyme-linked immunosorbent assay.
Lee JB; Fumimori T; Kurose K; Mori O; Hashimoto T
J Dermatol; 2003 Apr; 30(4):326-31. PubMed ID: 12707470
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in Japan.
Ujiie H; Arakawa M; Aoyama Y
J Dermatol Sci; 2023 Jan; 109(1):22-29. PubMed ID: 36697305
[TBL] [Abstract][Full Text] [Related]
17. A case of severe bullous pemphigoid treated with plasmapheresis.
Lee MW; Lee WS; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatolog Treat; 2001 Mar; 12(1):59-60. PubMed ID: 12171691
[No Abstract] [Full Text] [Related]
18. [Therapeutic use of plasmapheresis in a patient with bullous pemphigoid].
Bandemir W; Krëger E
Vestn Dermatol Venerol; 1989; (2):10-3. PubMed ID: 2658406
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption for the treatment of bullous pemphigoid.
Ino N; Kamata N; Matsuura C; Shinkai H; Odaka M
Ther Apher; 1997 Nov; 1(4):372-6. PubMed ID: 10225735
[TBL] [Abstract][Full Text] [Related]
20. Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.
Yan T; Xie Y; Liu Y; Shan Y; Wu X; Wang J; Zuo YG; Zhang Z
Front Immunol; 2023; 14():1194088. PubMed ID: 37575240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
